BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7899675)

  • 41. Non-small cell lung cancer: second-line and beyond.
    Stahel RA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x97-100. PubMed ID: 17018760
    [No Abstract]   [Full Text] [Related]  

  • 42. Should non-small cell carcinoma of the lung be treated with chemotherapy? Con: therapeutic empiricism--the case against chemotherapy in non-small cell lung cancer.
    Douglas IS; White SR
    Am J Respir Crit Care Med; 1995 May; 151(5):1288-91. PubMed ID: 7735575
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemotherapy in stage IV lung cancer (take home messages).
    Eberhardt W; Wolf M
    Lung Cancer; 2001 Sep; 33 Suppl 1():S121-3. PubMed ID: 11576717
    [No Abstract]   [Full Text] [Related]  

  • 44. Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.
    Gebbia V; Galetta D; De Marinis F
    Ann Oncol; 2005 May; 16 Suppl 4():iv123-131. PubMed ID: 15923412
    [No Abstract]   [Full Text] [Related]  

  • 45. Should non-small cell carcinoma of the lung be treated with chemotherapy? Pro: chemotherapy is for non-small cell lung cancer.
    Masters GA; Vokes EE
    Am J Respir Crit Care Med; 1995 May; 151(5):1285-7. PubMed ID: 7735574
    [No Abstract]   [Full Text] [Related]  

  • 46. Cetuximab and non-small-cell lung cancer: end of the story?
    Rossi A
    Lancet Oncol; 2013 Dec; 14(13):1251-3. PubMed ID: 24231626
    [No Abstract]   [Full Text] [Related]  

  • 47. Lung cancer with cavitation: a distinct subgroup of non-small cell lung cancer associated with poor overall survival.
    Singh N; Behera D
    Respir Investig; 2015 May; 53(3):133-4. PubMed ID: 25951101
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemotherapy in patients with advanced non-small cell lung cancer.
    Price A
    Clin Oncol (R Coll Radiol); 2001; 13(6):480-2. PubMed ID: 11824892
    [No Abstract]   [Full Text] [Related]  

  • 49. Is the use of chemotherapy justified in non-small-cell lung cancer?
    Kelly P; Clancy L
    Drugs Aging; 1994 Jan; 4(1):1-8. PubMed ID: 8130379
    [No Abstract]   [Full Text] [Related]  

  • 50. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Besse B
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii30-1. PubMed ID: 17491035
    [No Abstract]   [Full Text] [Related]  

  • 51. [The question and analysis about maintenance therapy in advanced non-small cell lung cancer].
    Liu X
    Zhongguo Fei Ai Za Zhi; 2014 Apr; 17(4):289-93. PubMed ID: 24758902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy in non-small cell lung cancer. Quality of life was ignored in meta-analysis.
    Higginson I
    BMJ; 1996 Jan; 312(7025):249. PubMed ID: 8563604
    [No Abstract]   [Full Text] [Related]  

  • 53. Is chemotherapy for non-small cell lung cancer worthwhile?
    Coates A; Forbes J
    Lancet; 1993 Jul; 342(8862):4. PubMed ID: 8100297
    [No Abstract]   [Full Text] [Related]  

  • 54. Lung cancer: cetuximab, you're fired.
    Villanueva MT
    Nat Rev Clin Oncol; 2014 Jan; 11(1):3. PubMed ID: 24281063
    [No Abstract]   [Full Text] [Related]  

  • 55. Chemotherapy of non-small cell lung cancer.
    McVie JG
    Ann Oncol; 1993 Dec; 4(10):804-5. PubMed ID: 8117598
    [No Abstract]   [Full Text] [Related]  

  • 56. Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice.
    Cullen M; Szczepura A; Thomas M; Kielhorn A
    Lung Cancer; 2004 Jan; 43(1):113-5. PubMed ID: 14698545
    [No Abstract]   [Full Text] [Related]  

  • 57. [Economic analysis of home based versus hospital outpatient chemotherapy in stage IV non small cell lung cancer].
    Vergnenègre A; Decroisette C; Vincent F; Dalmay F; Melloni B; Bonnaud F; Eichler B
    Rev Mal Respir; 2006 Jun; 23(3 Pt 1):255-63. PubMed ID: 16788526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintenance chemotherapy in non-small cell lung cancer.
    Rinaldi M; Belvedere O; Cauchi C; Defferrari C; Viola G; Grossi F
    Ann Oncol; 2006 Mar; 17 Suppl 2():ii67-70. PubMed ID: 16608989
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment for early-stage lung cancer: what next?
    Paz-Ares L; Corral J
    Lancet; 2014 May; 383(9928):1528-30. PubMed ID: 24576775
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclooxygenase 2 inhibition in patients with non-small cell lung cancer: Is this still a valid target for therapy?
    Gadgeel SM
    Cancer; 2015 Sep; 121(18):3197-200. PubMed ID: 26033783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.